Abstract

 Cancer has been the major cause of morbidity and mortality all over the world. Even though cancer therapy has new ways of treatment by chemotherapy and radiotherapy, resistance to treatment has become the major cause for mortality of patients. It has lead to decrease in lifespan of patients even after treatment.
The present review deals with Stem cells (SC), Cancer stem cells (CSC),Epithelial Mesenchymal Transition (EMT)and various aspects of cells leading to drug resistance. The characteristics of CSC like Dormancy, surrounding aspects of tumor like Hypoxia, Tumor microenvironment and Cancer Nische act on the tumor cells in various ways leading to Drug resistance.
Understanding of these various aspects helps in dealing with cancer drug resistance, its effects and various ways to improve tumor response and treatment.

Keywords: Cancer Stem Cell;Epithelial Mesenchymal Transition; Tumor Microenvironment; Drug Resistance

References

1. Siegal Rebecca KD Miller and Ahmddin Jemal. "Cancer statistics, 2012”. CA: A Cancer Journal for Clinicians 1 (2014): 9-29.
2. Lawson, Devon A., et al. "Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells”. Nature 7571 (2015): 131-135.
3. Luqmani YA. "Mechanisms of drug resistance in cancer chemotherapy”. Medical Principles and Practice1 (2005): 35-48.
4. Muhammad Al-Hajj., et al. “Prospective identification of tumorigenic breast cancer cells”. Proceedings of the National Academy of Sciences of the United States of America 7 (2003): 3983-3988.
5. Valent Peter., et al. "Cancer stem cell definitions and terminology: the devil is in the details”. Nature Reviews Cancer 11 (2012): 767-775.
6. Ignatova Tatyana N., et al. "Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers In vitro”. Glia3 (2002): 193-206.
7. Al-Hajj Muhammad., et al. "Prospective identification of tumorigenic breast cancer cells”. Proceedings of the National Academy of Sciences7 (2003): 3983-3988.
8. Bonnet Dominique and John E Dick. "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell”. Nature Medicine7 (1997): 730-737.
9. Liu Chunfang., et al. "Multiple tumor types may originate from bone marrow-derived cells”. Neoplasia (New York, NY)9 (2006): 716.
10. Baccelli Irène and Andreas Trumpp. "The evolving concept of cancer and metastasis stem cells”. Journal of Cell Biology3 (2012): 281-293.
11. Friedmann-Morvinski Dinorah., et al. "Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice”. Science 6110 (2012): 1080-1084.
12. Chen K., et al. "Understanding and targeting cancer stem cells: therapeutic implications and challenges”. Acta Pharmacologica Sinica6 (2013): 732-740.
13. Klonisch Thomas., et al. "Cancer stem cell markers in common cancers–therapeutic implications”. Trends in Molecular Medicine10 (2008): 450-460.
14. Thiery Jean Paul., et al. "Epithelial-mesenchymal transitions in development and disease”. Cell 5 (2009): 871-890.
15. Cano Amparo., et al. "The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression”. Nature cell Biology2 (2000): 76-83.
16. Takahashi Kazutoshi., et al. "Induction of pluripotent stem cells from adult human fibroblasts by defined factors”. Cell 5 (2007): 861-872.
17. Kong Ying., et al. "Twist1 and Snail link Hedgehog signaling to tumor‐initiating cell‐like properties and acquired chemoresistance independently of ABC transporters”. Stem Cells4 (2015): 1063-1074.
18. Carnero A., et al. "The cancer stem-cell signaling network and resistance to therapy”. Cancer Treatment Reviews 49 (2016): 25-36.
19. Khoo Bee Luan., et al. "Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy”. Oncotarget17 (2015): 15578.
20. Maheswaran Shyamala and Daniel A Haber. "Cell fate: Transition loses its invasive edge”. Nature 7579 (2015): 452-453.
21. Vega Sonia., et al. "Snail blocks the cell cycle and confers resistance to cell death”. Genes and Development 10 (2004): 1131-1143.
22. Housman G., et al. "Drug resistance in cancer: an overview”. Cancers (Basel) 6 (2014): 1769-1792.
23. Lippert Theodor H., et al. "Intrinsic and acquired drug resistance in malignant tumors”. Arzneimittelforschung06 (2008): 261-264.
24. Burrell Rebecca A., et al. "The causes and consequences of genetic heterogeneity in cancer evolution”. Nature7467 (2013): 338-345.
25. Ding Li., et al. "Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing”. Nature 7382 (2012): 506-510.
26. Challagundla Kishore B., et al. "Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy”. JNCI: Journal of the National Cancer Institute7 (2015).
27. Retsky Michael and Romano Demicheli. "Multimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation”. Cancers 4 (2014): 2343-2355.
28. Takubo Keiyo., et al. "Regulation of the HIF-1α level is essential for hematopoietic stem cells”. Cell Stem Cell3 (2010): 391-402.
29. Endo Hiroko and Masahiro Inoue. "Dormancy in cancer”. Cancer Science2 (2019): 474-480.
30. Hanahan Douglas and Lisa M Coussens. "Accessories to the crime: functions of cells recruited to the tumor microenvironment”. Cancer Cell3 (2012): 309-322.
31. Anton Kevin and John Glod. "Targeting the tumor stroma in cancer therapy”. Current Pharmaceutical Biotechnology2 (2009): 185-191.
32. Simon M Celeste and Brian Keith. "The role of oxygen availability in embryonic development and stem cell function”. Nature Reviews Molecular Cell Biology4 (2008): 285-296.
33. Semenza Gregg L. "Hydroxylation of HIF-1: oxygen sensing at the molecular level”. Physiology4 (2004): 176-182.
34. Semenza Gregg L. "Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics”. Oncogene 5 (2010): 625-634.
35. Vaupel Peter., et al. "Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy”. Seminars in Oncology 8 (2001): 29-35.
36. Casazza Andrea., et al. "Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment”. Oncogene14 (2014): 1743-1754.
37. Lee Chen-Ting., et al. "Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?”. International Journal of Hyperthermia3 (2010): 232-246.
38. Sica Antonio and Alberto Mantovani. "Macrophage plasticity and polarization: In vivo veritas”. The Journal of Clinical Investigation3 (2012): 787-795.
39. Andreesen Reinhard., et al. "Adoptive immunotherapy of cancer using monocyte‐derived macrophages: rationale, current status, and perspectives”. Journal of Leukocyte Biology4 (1998): 419-426.
40. Kessenbrock Kai., et al. "Matrix metalloproteinases: regulators of the tumor microenvironment”. Cell1 (2010): 52-67.
41. Hanno JrMG., et al. "Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis”. Journal of the National Cancer Institute5 (1972): 1441-1455.
42. Li Linheng and Ting Xie. "Stem cell niche: structure and function”. Annual Review of Cell and Developmental Biology 21 (2005): 605-631.
43. Jones DLeanne and Amy J Wagers. "No place like home: anatomy and function of the stem cell niche”. Nature Reviews Molecular Cell Biology1 (2008): 11-21.
44. Broz Miranda L., et al. "Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity”. Cancer Cell5 (2014): 638-652.
45. Cabarcas Stephanie M., et al. "The cancer stem cell niche-there goes the neighborhood?”. International Journal of Cancer10 (2011): 2315-2327.
46. Reagan Michaela R and David L Kaplan. "Concise review: mesenchymal stem cell tumor‐homing: detection methods in disease model systems”. Stem Cells6 (2011): 920-927.
47. Fessler Evelyn., et al. "Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?”. Cancer Letters1 (2013): 97-104.
48. Basak U., et al. "Deciphering the Cancer Puzzle: Cancer Stem Cells Being the Pivotal Piece”. Journal of Stem Cell Research and Transplantation 1 (2017): 1025.

Citation

Citation: Nandini NM. “Cancer Stem Cells and Drug Resistance”.Acta Scientific Cancer Biology 4.6 (2020): 12-18.

Copyright

Copyright: © 2020 Nandini NM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.